Other industry list-toppers included MiMedx, Cytokinetics, C.R. Bard, and Spectrum.
Here are Tuesday's top research calls, including downgrades for Amazon and C.R. Bard, and new coverage of CyrusOne and Dow Chemical.
Jim Cramer says a rally on French election results is fine, but don't forget great U.S. corporate earnings and merger activity.